WELLESLEY, Mass.– The Vascular Care Group, a state-of-the art practice committed to the prevention, diagnosis and treatment of vascular disease, is pleased to announce that Dr. Lawrence Garcia has joined the Wellesley center. Lawrence A. Garcia, MD, FACC, FAHA, FSCAI, is a Board-certified interventional cardiologist with a focus on peripheral vascular disease. He will work alongside Christopher J. Kwolek, MD, MBA, FACS, R. Todd Lancaster, MD, MPH, RPVI, and Zachary B. Fang, MD, MSc.
“Dr. Garcia brings a wealth of experience in the management of patients with peripheral arterial disease and coronary artery disease, as well as extensive clinical trial experience,” said Dr. Christopher Kwolek. “He has served as a principal investigator on several national and international trials evaluating therapies for peripheral vascular disease. His research has been published in numerous manuscripts and book chapters. In addition, he has served as a course director for many national educational programs and as faculty for more than 50 national and international conferences. He will be an outstanding contributor to our organization and to the management of patients at our Wellesley site.”
Prior to joining The Vascular Care Group, Dr. Garcia received his undergraduate and doctoral degrees from the University of Arizona. He completed his internship and residency at UT-Southwestern, Parkland Hospital in Dallas, Texas. He was a research fellow in the field of aerospace cardiology at that time. He went on to complete additional fellowships in cardiovascular diseases at the University of Iowa Hospital and Clinics, interventional cardiology at the Beth Israel Deaconess Medical Center at Harvard Medical School, and vascular medicine and interventions at St. Elizabeth’s Medical Center at Tufts University School of Medicine. He has since gone on to train over 100 fellows throughout his career.
“Bringing my practice to The Vascular Care Group is a very unique and exciting opportunity,” said Dr. Garcia. “It develops a whole new direction to practice cardiology and interventional medicine in a way that best serves our patients. It remains my greatest honor to be given the privilege of caring for patients and their families as a physician.”
Over the course of his career, Dr. Garcia has directed several multi-center national and international trials for endovascular methods, and his work has earned him numerous accolades including Top Doctor of Boston in Interventional Cardiology by Castle Connolly Associates and Boston’s Top Doctors by Boston Magazine for the past 10 consecutive years. He has been a key contributor in 35 original articles, including being principal investigator for the Definitive LE trial for lower extremity revascularization using directional atherectomy as well as principal investigator in the SUPERB Trial, which was the study that led to the worldwide use of the Supera™ stent. His international recognition has given him the opportunity to lecture all around the world, including Asia, Australia, Europe, and South America.
He is currently a Professor of Medicine at Tufts University School of Medicine in Boston. He is a member of numerous professional societies, including: American College of Cardiology, American Heart Association and the Society of Cardiovascular Angiography and Interventions (SCAI), among others.
“Over the course of my career, I have been given many opportunities. The best ones, however, have been the opportunities to treat patients and their families as well as train physicians in the care of patients with cardiovascular diseases,” Garcia said.
